Related Experiment Videos
Cutaneous lesions in systemic lupus erythematosus
1Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
The Medical Clinics of North America
|September 1, 1989
Summary
This review details skin manifestations in systemic lupus erythematosus, covering their appearance, pathology, and links to serology. Understanding these cutaneous features aids in diagnosis and predicting patient outcomes.
Area of Science:
- Dermatology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) frequently presents with diverse cutaneous manifestations.
- Skin lesions can be the initial sign or appear during the disease's progression.
- Understanding these dermatological signs is crucial for SLE diagnosis and management.
Purpose of the Study:
- To comprehensively describe the range of cutaneous lesions in systemic lupus erythematosus.
- To correlate skin findings with histopathologic features and serologic markers.
- To discuss the prognostic significance of specific cutaneous manifestations.
Main Methods:
- Review of clinical presentations of cutaneous lesions in SLE.
- Analysis of histopathologic findings associated with SLE skin manifestations.
- Correlation of dermatological signs with serological markers (e.g., autoantibodies).
Main Results:
- Detailed description of various lupus-specific and lupus-associated skin lesions.
- Explanation of the histopathologic characteristics of these lesions.
- Discussion of the link between specific skin findings and disease activity or prognosis.
Conclusions:
- Cutaneous manifestations are integral to the clinical spectrum of systemic lupus erythematosus.
- Histopathology and serology provide essential context for understanding SLE skin disease.
- The nature of skin lesions can offer insights into prognosis and guide treatment strategies.